Gilead Sciences Inc buy marge
Start price
21.06.15
/
50%
€106.30
Target price
24.05.16
€120.00
Performance (%)
-28.58%
End price
24.05.16
€74.75
Summary
This prediction ended on 24.05.16 with a price of €74.75. The prediction for Gilead Sciences Inc disappointed with a performance of -28.58%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gilead Sciences Inc | -1.539% | -1.539% | 15.398% | 23.488% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by marge for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)
Stopped prediction by marge for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.59
03.05.20
03.05.20
€90.00
04.11.21
04.11.21
-25.71%
05.11.21
05.11.21
